Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-02

Clinical Trial Update: Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial update suggests that dronabinol may enhance behavioral therapy for fibromyalgia and low back pain, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronabinol (dronabinol)

Snippet

Sponsor: Heidelberg University | Conditions: Fibromyalgia, Back Pain | Phase 2 | Status: COMPLETED